Navigation Links
3SBio Inc. Announces Receipt of "Going Private" Proposal at $15 Per ADS
Date:9/12/2012

posal. There can be no assurance that any definitive offer will be made, that any agreement will be executed or that this or any other transaction will be approved or consummated.

About 3SBio Inc.

3SBio is a leading, fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China.  Its focus is on addressing large markets with significant unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases.  With headquarters and GMP-certified manufacturing facilities in Shenyang, PRC, 3SBio employs over 800 people. Shares trade in the form of American Depositary Shares (ADSs) on the NASDAQ stock market under the ticker symbol "SSRX". Please see www.3SBio.com for more information.

Cautionary Statement concerning Forward Looking Statements

This press release includes statements that may constitute forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements.  Statements that are not historical facts, including statements about 3SBio's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. Potential risks and uncertainties include, but are not limited to, risks outlined in 3SBio's filings with the U.S. Securities and Exchange Commission. 3SBio does not undertake any obligation to update any forward-looking statement, except
'/>"/>

SOURCE 3SBio Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. 3SBio Inc. to Hold 2012 Annual General Meeting on October 10, 2012
2. Apexigen Announces the Filing of an IND by its Partner, 3SBio
3. 3SBio Inc. Announces Changes to Its Board of Directors
4. 3SBio Inc. Schedules Unaudited Second Quarter 2012 Results
5. 3SBio Obtains SFDA Approval to Join Global Phase III Trial for Voclosporin
6. 3SBio Inc. To Present at the DB Access Asia Conference 2012
7. 3SBio Inc. Schedules Unaudited First Quarter 2012 Results
8. IncellDx, Inc. Announces an Agreement with BioReference Laboratories, Inc. to Conduct a 10,000 Sample Study Using a Slideless Pap Smear
9. Apexus Announces HRSAs 340B Prime Vendor Contract Renewal
10. NuAire Announces New In-VitroCell Energy Saver CO2 Incubators
11. Thoratec Announces Presentations At Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... 2015  New York College of Health Professions announces ... portfolio with U.S. Patent #8,996,098 donated by its Chairman ... a surgical instrument that allows surgeons to view and ... in the traditional format of a slide that is ... during surgery, thus providing the surgeon real time analysis ...
(Date:4/1/2015)... ASPEN, Colo. , April 1, 2015  Astellas ... (CKF), is pleased to sponsor the second annual Bounce ... award, which will recognize two transplant recipients who exhibit ... a career accomplishment, participation in a sport or hobby, ... loved ones. "The Bounce Back Award ...
(Date:4/1/2015)... 2015  The fairness of the proposed acquisition of ... Pharmaceutical Industries ("Teva") is being investigated by WeissLaw LLP, ... investigation focuses on possible breaches of fiduciary duty and ... of ASPX for agreeing to sell the Company to ... definitive agreement for Teva to acquire ASPX in a ...
Breaking Medicine Technology:Ground-Breaking Surgical Instrument Allows Surgeons to obtain Real Time Biopsies 2Ground-Breaking Surgical Instrument Allows Surgeons to obtain Real Time Biopsies 3Astellas Teams Up with The Chris Klug Foundation on the Bounce Back Award to Recognize Extraordinary Transplant Recipients 2Astellas Teams Up with The Chris Klug Foundation on the Bounce Back Award to Recognize Extraordinary Transplant Recipients 3WeissLaw LLP: Auspex Pharmaceuticals Inc. Acquisition By Teva Pharmaceutical Industries May Not Be In The Best Interest of ASPX Shareholders 2
... Recent Highlights: Qutenza ® (capsaicin) ... adoption by large US institutions; 238 hospitals purchased as of 4Q10, ... Q4 2010 revenue totaled $2.3 million including $0.5 million U.S. Qutenza ... in 17 countries at December 31, 2010 NGX-1998 Phase 2 ...
... March 30, 2011 Rochester Medical Corporation (Nasdaq: ... BioSciences N.V. today approved the previously announced sale of ... subsidiary to Rochester Medical Corporation. Rochester Medical ... and under the terms of the Share Purchase Agreement ...
Cached Medicine Technology:NeurogesX Reports Fourth Quarter and Year-End 2010 Results 2NeurogesX Reports Fourth Quarter and Year-End 2010 Results 3NeurogesX Reports Fourth Quarter and Year-End 2010 Results 4NeurogesX Reports Fourth Quarter and Year-End 2010 Results 5NeurogesX Reports Fourth Quarter and Year-End 2010 Results 6NeurogesX Reports Fourth Quarter and Year-End 2010 Results 7NeurogesX Reports Fourth Quarter and Year-End 2010 Results 8NeurogesX Reports Fourth Quarter and Year-End 2010 Results 9Fornix Shareholders Approve the Sale of Laprolan B.V. to Rochester Medical Corporation 2
(Date:4/1/2015)... Like a mosaic slowly gaining definition and becoming ... potential causes of rosacea. April has been designated as ... to educate the public on the warning signs of ... affect more than 16 million Americans. , The ... its patient-funded research grants program, awarding $1.4 million to ...
(Date:4/1/2015)... FL (PRWEB) April 01, 2015 IQ ... growing health and nutritional supplement companies in the U.S., today ... the testing and quality control standards for its herbal supplements.* ... the supply chain to ensure the accuracy of labeling on ... industry veteran and IQ Formulations CEO Jay Cohen ...
(Date:4/1/2015)... April 01, 2015 Health Advocate™, Inc., ... a subsidiary of West Corporation, today launched its new ... http://blog.healthadvocate.com and through the Health Advocate member website, ... get, and stay, healthy. , “We’re pleased to introduce ... the public,” said Martin Rosen, Executive Vice President, Health ...
(Date:4/1/2015)... When annoying or concerning skin conditions such as ... an appointment with a dermatologist is the last thing ... been possible within dermatology. However, in the Sheboygan and ... for this level of service and are answering consumer’s ... answers to dermatological issues are to our patients, and ...
(Date:4/1/2015)... Senior Helpers of Central Texas has been ... Award by Home Care Pulse. The Best of Home Care ... care providers who receive the highest satisfaction scores from their ... care. This recognition reassures you that your home care provider ... quality, trustworthy in home care. , In order to qualify, ...
Breaking Medicine News(10 mins):Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 2Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 3Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 4Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 5Health News:IQ Formulations Applauds GNC for Enhancing Its Testing and Quality Control Processes for Herbal Supplements 2Health News:Health Advocate Launches New Health and Wellness Blog 2Health News:Dermatology Associates of Wisconsin and Forefront Dermatology Answers Patients' Needs With Unmatched Availability In Sheboygan and Sheboygan Falls 2Health News:Senior Helpers of Central Texas Awarded Prestigious 2015 Senior Home Care Provider of Choice Award from Home Care Pulse 2
... ... as a Magnet hospital for nursing excellence from the American Nurses Credentialing Center (ANCC). ... La ... re-designation as a Magnet hospital for nursing excellence from the American Nurses Credentialing Center ...
... ... Device Control for everyone: Protect your PC and files at ... and eliminate threats of portable storage devices (USB Flash Drives, external ... ports on PCs and MACs,• Free data loss and theft protection for ...
... in aging Boomers seeking help for drug abuse, study finds ... 50 and older, admissions for drug abuse treatment have nearly ... Admissions for cocaine, heroin, prescription drugs, and/or marijuana abuse among ... percent in 1992 to just over 12 percent by 2008, ...
... science class that light beams travel in straight lines and ... can,t go around corners. But now researchers at Tel Aviv ... small beams of light can indeed be bent in a ... These rays, called "Airy beams," were named after English ...
... helped solve a global environmental crisis in the 1990s ... may be making another problem acid rain ... that replaced the ozone-destroying chlorofluorocarbons (CFCs) once used in ... appears in ACS, Journal of Physical Chemistry A, a ...
... ... to post learning points from the APTA 2010 conference this June. , ... Philadelphia, PA (PRWEB) June ... for physical therapy professionals— DavisPTnetwork — has recruited several bloggers to post key ...
Cached Medicine News:Health News:Scripps Memorial Hospital La Jolla First in San Diego to Achieve Magnet Nursing Re-designation 2Health News:Scripps Memorial Hospital La Jolla First in San Diego to Achieve Magnet Nursing Re-designation 3Health News:My Endpoint Protector Device Control is Now Available for Home Users Free of Charge 2Health News:My Endpoint Protector Device Control is Now Available for Home Users Free of Charge 3Health News:My Endpoint Protector Device Control is Now Available for Home Users Free of Charge 4Health News:'Graying' of Drug Users at U.S. Treatment Centers 2Health News:Shining a light around corners 2Health News:DavisPTnetwork Recruits Bloggers to Report Key Session Learning Points Live from APTA 2010 2
... HER2 FISH pharmDx Kit is a direct ... to quantitatively determine HER2 gene amplification in ... amplification is determined from the ratio between ... of the HER2 gene probe (red signals) ...
... only HER-2 assessment test approved by the ... three claims: prognosis, adriamycin-based chemotherapy selection and ... is the only FISH-based DNA probe HER-2 ... as an appropriate test to aid in ...
... Innovators in Anesthesia and Respiratory Products, ... quality medical devices for Anesthesia and Respiratory ... manufacture products that enhance the clinician's ability ... close attention to the bottom line. , ...
... OMNI~NEB delivers breakthrough continuous low-flow nebulizer ... precise nozzle technology allows for optimal ... or without Heliox). OMNI~NEB takes on ... both routine and critical care situations. ...
Medicine Products: